Midazolam Hydrochloride Injection
Brand names: Midazolam, Midazolam Hydrochloride
Category: Anesthesia, Neurology
Unavailable 10Limited 3Available 14
FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Apr 2, 2020 (in shortage 6 years 5 months) · 6 manufacturers, 27 listed presentations
As of Sep 22, 2026, the FDA lists Midazolam Hydrochloride Injection as currently in shortage. Of 27 manufacturer presentations, 10 Unavailable, 3 Limited, 14 Available.
Ask your pharmacist: which of the 6 manufacturers below can they order right now, and whether a different strength or form of Midazolam Hydrochloride Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) NDC 63323-411-10 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) NDC 25021-655-02 |
Gland Pharma Limited | Unavailable | Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) NDC 23155-600-41 |
Avet Pharmaceuticals, Inc. | Limited | Estimated recovery: 9/25/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) NDC 63323-411-25 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) NDC 63323-411-12 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) NDC 0641-6056-10 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) NDC 0641-6059-01 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) NDC 0641-6057-25 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) NDC 44567-610-10 |
WG Critical Care | Available | Please check wholesalers and distributors for inventory. |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) NDC 44567-611-10 |
WG Critical Care | Available | Please check wholesalers and distributors for inventory. |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) NDC 76045-211-20 |
Fresenius Kabi USA, LLC | Unavailable | Next release October 2026. Check wholesalers for inventory. |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) NDC 63323-412-25 |
Fresenius Kabi USA, LLC | Unavailable | Next release October 2026. Check wholesalers for inventory. |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) NDC 63323-412-10 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) NDC 25021-661-10 |
Gland Pharma Limited | Unavailable | Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) NDC 23155-601-41 |
Avet Pharmaceuticals, Inc. | Available | - |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) NDC 23155-601-42 |
Avet Pharmaceuticals, Inc. | Available | - |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) NDC 63323-412-02 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) NDC 0641-6060-10 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) NDC 0641-6061-25 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. |
| Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) NDC 0409-2308-02 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery and Estimated Recovery: September 2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25) NDC 0409-0001-25 |
Hospira, Inc., a Pfizer Company | Limited | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) NDC 0409-2305-17 |
Hospira, Inc., a Pfizer Company | Limited | Next Estimated Delivery and Estimated Recovery: December 2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) NDC 0409-2305-05 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery: October 2026; Estimated Recovery: December 2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) NDC 0409-2308-01 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery and Estimated Recovery: December 2026 |
| Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) NDC 0409-2587-05 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery and Estimated Recovery: December 2026 |
| Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) NDC 0409-2596-03 |
Hospira, Inc., a Pfizer Company | Available | - |
| Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) NDC 0409-2596-05 |
Hospira, Inc., a Pfizer Company | Available | - |
Related medications in shortage
Other Anesthesia, Neurology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Midazolam Hydrochloride Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Midazolam Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Midazolam Hydrochloride Injection.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/midazolam-hydrochloride-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).